Saranac Partners Ltd

Position in JNJ — Johnson & Johnson

CIK 2098745 LONDON, X0

Position in JNJ

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$409,399

-$276,608 QoQ

Shares Held

1,612

-89.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#3,893

of 4,664 holders

Holding Since

Mar 2023

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Saranac Partners Ltd holds $13,142,776 across 6 Drug Manufacturers - General names. JNJ ranks #6 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	41,086	$10,338,881
2	AZN	Astrazeneca PLC	4,522	$857,461
3	LLY	ELI LILLY & Co	487	$584,122
4	NVO	Novo Nordisk A S	11,090	$531,654
5	BMY	Bristol Myers Squibb Co	7,311	$421,259
6	JNJ	Johnson & Johnson This page	1,612	$409,399

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$409,399	1,612	-89.7%	Shares	Sole	2026-08-13
2026-03-31	$686,007	15,632	+854.9%	Shares	Sole	2026-05-15
2025-12-31	$338,777	1,637	+10.5%	Shares	Sole	2026-02-06
2025-09-30	$274,788	1,482	+8.0%	Shares	Sole	2025-12-05
2025-06-30	$209,573	1,372	-0.3%	Shares	Sole	2025-12-15
2023-09-30	$214,312	1,376	0.0%	Shares	Sole	2026-02-02
2023-06-30	$227,755	1,376	0.0%	Shares	Sole	2026-02-06
2023-03-31	$213,280	1,376	—	Shares	Sole	2026-02-06
No filing history on record for this holder in this stock.